Latanoprost Vir

Latanoprost, the active ingredient in Latanoprost Vir, is a prostaglandin analog presented as an ophthalmic solution for ocular (topical) use. It treats open‑angle glaucoma and ocular hypertension by lowering intraocular pressure in adult patients.\n\nGNH India supplies Latanoprost Vir as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is an ocular hypotensive agent that reduces intraocular pressure in glaucoma‑related conditions.\n\nOpen‑angle glaucoma: lowers intraocular pressure to prevent optic nerve damage.\nOcular hypertension: reduces elevated eye pressure to lower risk of progression to glaucoma.\nElevated intraocular pressure: helps maintain target pressure levels in patients at risk of glaucomatous damage.

Latanoprost may cause a range of ocular and systemic reactions.\n\nCommon Side Effects:\n- Eye redness or hyperemia\n- Increased eyelash length or density\n- Iris color darkening (especially in brown eyes)\n- Eye irritation or foreign‑body sensation\n- Blurred vision\n- Mild ocular discomfort\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (e.g., angioedema)\n- Ocular inflammation or uveitis\n- Paradoxical increase in intraocular pressure\n- Corneal edema or keratitis\n- Vision loss or sudden visual disturbances\n- Persistent eye pain

Before using Latanoprost, consider the following safety measures.\n\nPregnancy: safety not established; avoid unless benefit outweighs risk.\nBreastfeeding: unknown excretion; use with caution.\nHypersensitivity: contraindicated in patients with known allergy to latanoprost or excipients.\nMonitoring: assess intraocular pressure after initiation and periodically thereafter.\nContact lens wearers: may develop deposits; consider removal before instillation.\nStore at room temperature: keep bottle tightly closed, protect from light and freezing.

Latanoprost can interact with other ocular or systemic agents affecting intraocular pressure.\n\nMajor Interactions (Avoid):\n- Other prostaglandin analog eye drops: risk of excessive pressure lowering.\n- Systemic prostaglandin analogs: potential additive hypotensive effect.\n\nModerate Interactions (Monitor Closely):\n- Topical NSAID eye drops: may diminish latanoprost efficacy.\n- Beta‑blocker eye drops: additive IOP reduction, monitor pressure.\n- Alpha‑agonist eye drops: possible synergistic effect on pressure lowering.